Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.460
-0.030 (-2.01%)
At close: Feb 21, 2025, 4:00 PM
1.450
-0.010 (-0.67%)
After-hours: Feb 21, 2025, 6:48 PM EST
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $80.95 million as of February 21, 2025. Its market cap has increased by 45.98% in one year.
Market Cap
80.95M
Enterprise Value
78.32M
1-Year Change
45.98%
Ranking
Category
Stock Price
$1.46
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $80.95M, a decrease of -84.26%. That is a compound annual growth rate of -42.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 80.95M | 78.33% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.92B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |